Tech Company Financing Transactions
Pressure BioSciences Funding Round
On 1/27/2016, Pressure BioSciences raised $5 million in funding from private investors.
Transaction Overview
Company Name
Announced On
1/27/2016
Transaction Type
Venture Equity
Amount
$5,010,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 22 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
14 Norfolk Ave.
South Easton, MA 02375
USA
South Easton, MA 02375
USA
Phone
Website
Email Address
Overview
We are a life sciences company focused on the development and commercialization of a novel, enabling, platform technology called pressure cycling technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Schumacher
Chief Scientific Officer
Alexander Lazarev
VP - Bus. Development
Bradford Young
VP - Engineering
Edmund Ting
VP - Finance
Joseph Damasio
Browse more venture capital transactions:
Prev: 1/27/2016: OneRent venture capital transaction
Next: 1/27/2016: Neurotrack Technologies venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs